|
|
Main Topics
Allergy and Asthma
- Allergic inflammation
- Genetics of asthma
- Asthma: different faces and different phenotypes
- Asthma exacerbations
- Epidemiology of asthma
- Asthma guidelines
- Education and delivery of care
- Asthma in the elderly
- Asthma and respiratory infections
- New therapies for asthma and allergies
- Specific immunotherapy in asthma
- Asthma and atopy in childhood
- Asthma and pregnancy
- Asthma and quality of life
- Stress and asthma
- Asthma and sports
- Tobacco smoke and asthma
- Atopy and asthma
- Allergy, asthma and vaccines
- Asthma and rhinitis
- Asthma and atopic dermatitis
- Food allergy and asthma
- New allergen-specific therapeutic strategies
- Genetic/environment interactions in preventing allergic diseases
- Basophil activation: Evaluation methods
- Complementary medicine in allergic disease, a fact of life: How should we respond?
- Sublingual allergen immunotherapy: Effective and safe
- Antihistamine preparations of new generation
- Risk factors in allergic children: A multiethical approach
- The impact of allergic diseases
- Atopic dermatitis
- Allergic conjunctivitis
- Allergens and bronchial obstruction
- New future treatments in allergy
- New perspectives in allergen immunotherapy
- Pollinosis in the world, old and new problems
- Recombinant allergens biological and clinical aspects
- Pre-IgE to IgE era: Four decades of clinical experience in allergic rhinitis
- How to modulate nasal inflammation in allergy
- T γ/δ cells in allergic nasal inflammation
- Nasal allergy and otitis media: Relationship and controversies
- Comorbidity in allergic rhinitis
- The ARIA Guidelines (asthma and rhinitis guidelines)
- Global Alliance against Respiratory Diseases (GARD)
- New insights into the pathophysiology of chronic urticaria
- Asthma: Different faces and different phenotypes
- Do we need asthma phenotypes?
- Chemokines in asthma
- Virus infections and atopic asthma – immunologic mechanisms
- Stress and asthma
- Role of dendritic cells in asthma
- Atopy and asthma genes
- Airways remodelling in asthma
- The role of T lymphocytes in the development of late phase allergic reactions in the lungs of asthma patients
- Cytokines of TNF family and asthma
- Role of environmental factors in allergy and asthma
- Epidemiology of asthma
- Treatment of severe asthma
- Immunotherapy in allergy and asthma
- Anti-IgE therapy
- Allergen peptide immunotherapy
- Anti-IL4 and IL5 therapies
- Asthma induced by pine tree pollen
- Aspirin-induced asthma
- Asthma and sports
Allergy
- The microbiome in health and allergic disease
- Drug allergy in children
- Treatment of rhinitis: Current standards and new concepts
- Early childhood asthma
- Mechanisms and complications of severe asthma
- Allergy prevention: The broad perspective
- New antiinflammatory treatments of asthma and allergy
- Regulation and standardization of allergen immunotherapy products
- Treatment of rhinosinusitis: State of the art
- Novel methods of prevention and treatment of atopic dermatitis
- Anti IgE for the treatment in allergy
- Food allergy: diagnosis and new treatment
- Regulation and standardization of allergen immunotherapy products
- Advances in molecular allergology in allergy diagnosis and treatment
COPD
- Genetic background of COPD
- Biomarkers in COPD
- Oxidative and nitrative stress: Control of cell function in COPD
- Airway inflammation in COPD
- Risk factors of COPD
- Smoking and COPD
- Exacerbation of COPD
- Epidemiology of COPD
- COPD: Environmental factors and socioeconomic impact
- Patient breathlessness in COPD
- COPD: the role of primary care
- COPD management
- COPD: a systemic disease affecting the muscles management on dynamic hyperinflation during exercise in COPD
- Systemic manifestations and comorbidities of COPD
- Modern methods of therapy in COPD
- Treatment of intermittent COPD
- COPD in childhood
- Modern methods of rehabilitation in COPD
- COPD guidelines
|
